Evidence map›Paper›PMID 23987193›Full record

ArticleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2013

Prescription fill patterns in underserved children with asthma receiving subspecialty care.

Mary E Bollinger, Kim E Mudd, Adam Boldt, Van Doren Hsu, Mona G Tsoukleris, Arlene M Butz

Abstract read
In one paragraph

Article in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Characteristics of inner-city children with life-threatening asthma.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2019
    Trial
  2. Factors associated with high short-acting β2-agonist use in urban children with asthma.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2015
    Trial
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Chronic stress and asthma in adolescents.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mary E BollingerDivision of Pediatric Pulmonology and Allergy, University of Maryland, Baltimore, Maryland, USA. mbolling@peds.umaryland.edu
Kim E Mudd
Adam Boldt
Van Doren Hsu
Mona G Tsoukleris
Arlene M Butz
University of Maryland, Baltimore · US

Funding

NEBULIZER INTERVENTION IN MINORITY CHILDREN WITH ASTHMAR01NR005060 · NINR · JOHNS HOPKINS UNIVERSITY · PI BUTZ, ARLENE MANNS · 2001 to 2004
$1.9M
NINR NIH HHS NR 05060NINR NIH HHS R01 NR005060
6 · The paper itself

Abstract

backgroundChildren with asthma receiving specialty care have been found to have improved asthma outcomes. However, these outcomes can be adversely affected by poor adherence with controller medications.

objectiveTo analyze pharmacy fill patterns as a measure of primary adherence in a group of underserved minority children receiving allergy subspecialty care.

methodsAs part of a larger 18-month nebulizer use study in underserved children (ages 2-8 years) with persistent asthma, 53 children were recruited from an urban allergy practice. Pharmacy records were compared with prescribing records for all asthma medications.

resultsAllergist controller prescriptions were written in 30-day quantities with refills and short-acting β-agonists (SABAs) with no refills. Only 49.1% of inhaled corticosteroid (ICS), 49.5% of combination ICS and long-acting β-agonist, and 64.5% of leukotriene modifier (LTM) initial and refill prescriptions were ever filled during the 18-month period. A mean of 5.1 refills (range, 0-14) for SABAs were obtained during 18 months, although only 1.28 SABA prescriptions were prescribed by the allergist. Mean times between first asthma prescription and actual filling were 30 days (range, 0-177 days) for ICSs, 26.6 days (range, 0-156 days) for LTMs, and 16.8 days (range, 0-139 days) for SABAs.

conclusionUnderserved children with asthma receiving allergy subspecialty care suboptimally filled controller prescriptions, yet filled abundant rescue medications from other prescribers. Limiting albuterol prescriptions to one canister without additional refills may provide an opportunity to monitor fill rates of both rescue and controller medications and provide education to patients about appropriate use of medications to improve adherence.

Indexed as

Adrenal Cortex HormonesAdrenergic beta-AgonistsAllergy and ImmunologyAnti-Asthmatic AgentsAsthmaChildChild, PreschoolDrug PrescriptionsHumansLeukotriene AntagonistsNebulizers and VaporizersPatient ComplianceSpecializationVulnerable PopulationsAdrenal Cortex HormonesAdrenergic beta-AgonistsAnti-Asthmatic AgentsLeukotriene Antagonists

Identifiers

PMID23987193
PMCPMC3758557
OpenAlexW2146742701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.